Last checked at 7 Apr 2021 17:59
Ap19
FORM 8.3
Amendment to sales
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | WILLIS TOWERS WATSON PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 01 April 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
| Long | Short | ||||
| Number | (%) | Number | (%) | ||
(1) | Relevant securities | ||||
1,748,938 | 1.36% | 190,301 | 0.15% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
102,359 | 0.08% | 7,066 | 0.01% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
| purchase/sell: | 6,100 | 0.00% | 6,100 | 0.00% | |
|
|
|
| ||
| TOTAL: |
|
|
|
| |
1,857,397 | 1.44% | 203,467 | 0.16% | ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
| Purchase | 1 | 234.0300 USD |
| Purchase | 7 | 233.4000 USD |
| Purchase | 8 | 233.2350 USD |
| Purchase | 40 | 231.0400 USD |
| Purchase | 95 | 233.2500 USD |
| Purchase | 100 | 230.8900 USD |
| Purchase | 100 | 233.9600 USD |
| Purchase | 110 | 233.8314 USD |
| Purchase | 117 | 233.4180 USD |
| Purchase | 136 | 233.5913 USD |
| Purchase | 140 | 234.0928 USD |
| Purchase | 149 | 230.9526 USD |
| Purchase | 220 | 232.2895 USD |
| Purchase | 281 | 233.2165 USD |
| Purchase | 323 | 228.7325 USD |
| Purchase | 994 | 233.5168 USD |
| Purchase | 1,000 | 233.5741 USD |
| Purchase | 1,102 | 233.3006 USD |
| Purchase | 1,951 | 233.4707 USD |
| Purchase | 2,578 | 231.6473 USD |
| Purchase | 3,094 | 232.4596 USD |
| Purchase | 3,395 | 232.9444 USD |
| Purchase | 4,748 | 232.9691 USD |
| Purchase | 4,851 | 233.4254 USD |
| Purchase | 4,926 | 233.0058 USD |
| Purchase | 5,344 | 233.5900 USD |
| Purchase | 12,411 | 232.7435 USD |
| Purchase | 25,600 | 233.6600 USD |
| Sale | 2 | 233.9100 USD |
| Sale | 2 | 233.7100 USD |
| Sale | 8 | 233.9400 USD |
| Sale | 15 | 233.3120 USD |
| Sale | 38 | 233.5950 USD |
| Sale | 40 | 231.0400 USD |
| Sale | 92 | 232.9400 USD |
| Sale | 100 | 230.8900 USD |
| Sale | 100 | 230.3600 USD |
| Sale | 149 | 230.9526 USD |
| Sale | 200 | 233.4450 USD |
| Sale | 206 | 233.6292 USD |
| Sale | 274 | 233.0725 USD |
| Sale | 323 | 228.7325 USD |
| Sale | 500 | 232.8610 USD |
| Sale | 500 | 233.3740 USD |
| Sale | 615 | 232.8644 USD |
| Sale | 800 | 233.6064 USD |
| Sale | 1,115 | 233.3674 USD |
| Sale | 1,156 | 232.9751 USD |
| Sale | 1,736 | 232.8840 USD |
| Sale | 2,158 | 232.1661 USD |
| Sale | 3,152 | 233.0658 USD |
| Sale | 3,394 | 232.9443 USD |
| Sale | 4,720 | 232.9786 USD |
| Sale | 5,442 | 233.5900 USD |
| Sale | 11,783 | 232.4167 USD |
| Sale | 16,001 | 233.5232 USD |
| Sale | 19,200 | 233.6600 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | YES |
| Date of disclosure: | 7 Apr 2021 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection |
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
| Product name | Written or | Number of | Exercise | Type | Expiry |
| purchased | relevant securities | price |
| date | |
to which the option |
|
|
| ||
or derivative |
|
|
| ||
relates |
|
|
| ||
| Put Options | Purchased | -100 | 220.0000 | American | Jul 16, 2021 |
| Call Options | Purchased | 100 | 240.0000 | American | Jul 16, 2021 |
| Call Options | Purchased | 6,000 | 220.0000 | American | Jul 16, 2021 |
| Put Options | Purchased | -6,000 | 200.0000 | American | Jul 16, 2021 |
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210407005829/en/
Copyright Business Wire 2021